Mizuho
-
-
-
-
-
-
-
Enliven Therapeutics launches $250 million public stock offering
-
-
-
-
-
-
-
Mizuho Reiterates Neutral Rating on SailPoint Technologies Holdings (SAIL)
-
-
-
-
-
-
-
Mizuho on BridgeBio Pharma (BBIO): 'We believe that any such potential transient weakness could represent a potential entry point opportunity'
-
-
-
-
-
-
-
Mizuho Reiterates Neutral Rating on Adobe (ADBE)
-
-
-
-
-
-
-
Quantinuum closes $1.68 billion IPO at $60 per share
-
-
-
-
-
-
-
Netskope (NTSK) PT Lowered to $13 at Mizuho
-
-
-
-
-
-
-
Quantinuum prices IPO at $60 per share for 28 million shares
-
6,981 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

